DC Field | Value | Language |
dc.contributor.author | Cebotari, Inga | |
dc.date.accessioned | 2021-11-11T14:17:23Z | |
dc.date.available | 2021-11-11T14:17:23Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | CEBOTARI, Inga. Modern approach to epilepsy treatment. In: MedEspera: the 5th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2014, p. 111. | en_US |
dc.identifier.uri | http://repository.usmf.md/handle/20.500.12710/18471 | |
dc.description | State Medical and Pharmaceutical University “Nicolae Testemițanu”, Chișinău, Republic of Moldova | en_US |
dc.description.abstract | Introduction: Long regular use of antiepileptic drugs aimed at reducing frequency of seizures
or stopping them completely without any significant side-effects is by far the main principle of
epilepsy treatment. Attention is drawn to the issues of tolerability of antiepileptic therapy and
compliancy, mutual understanding between the physician and the patient.
Purpose and Objectives: To determine the response to treatment of patients presenting with
different types of seizures and the possibility of efficient therapeutic care of patients with epilepsy.
Materials and methods: This study is based on retrospective analysis of medical
documentation of patients hospitalized in 1MSP SCP. The study group was represented by 36
patients (19 men and 17 women) diagnosed with epilepsy.
Results: During this study, we have evaluated the response to antiepileptic treatment given to
patients presenting with different types of seizures. 21 patients (58%) had polymorphic seizures and 15
patients (42%) generalized tonic-clonic seizures. 26 patients (72%) received monotherapy and 10
patients (28%) were treated using polytherapy. Carbamazepine was used as monotherapy in 88% (23
patients) and valproate in 12% of the cases (3 patients). The polytherapy included double-therapy in
25% of cases (9 patients) and triple-therapy in 3% of the cases (1 patient). As the end result of the
treatment in patients with epilepsy, we have obtained an adequate control of seizures (absence of
seizures) in 36% of the cases (13 patients). A reduction of seizures’ frequency by more than 50% was
observed in 36% (13 patients) and the seizures’ frequency was unchanged in 28% of the cases (10
patients). Reported treatment failure was most likely due to the short term of treatment, although
refractory epilepsy in these patients is not excluded. Analyzing the adherence to treatment in ambulatory
conditions, we found that 24 patients (67%) complied with the recommendations and continued
treatment at home, while 12 patients (33%) dropped out of therapy.
Conclusions: The study shows that polymorphic seizures are better controlled by
monotherapy (37.5%-complete control) versus polytherapy (16.6%-complete control), whereas
generalized tonic-clonic seizures show positive response to polytherapy (50%) versus monotherapy
(30.7%). Polymorphic seizures have a good response (reduction o f >50% of seizures’ frequency)
with polytherapy (50%) versus monotherapy (37.5%), whereas generalized tonic-clonic seizures,
show similar response to both monotherapy and polytherapy. We’ve concluded that polymorphic
seizures have a better response to treatment when compared with generalized tonic-clonic seizures,
both in monotherapy and in polytherapy. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Ministry of Health of the Republic of Moldova, State Medical and Pharmaceutical University Nicolae Testemitanu, Medical Students and Residents Association | en_US |
dc.relation.ispartof | MedEspera: The 5th International Medical Congress for Students and Young Doctors, May 14-17, 2014, Chisinau, Republic of Moldova | en_US |
dc.subject | antiepileptic drugs | en_US |
dc.subject | efficacy of therapy | en_US |
dc.title | Modern approach to epilepsy treatment | en_US |
dc.type | Other | en_US |
Appears in Collections: | MedEspera 2014
|